Podcast
Independent pharmacies are getting closer to ending DIR fees for good, thanks to the work of organizations, such as the NCPA.
Today's episode features Jack Mozloom and guests Ronna Hauser and Karry La Violette from NCPA who discuss advocacy and regulatory issues with DIR.
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.